A new study has revealed alarming evidence of partial resistance to artemisinin, a crucial antimalarial drug, in Ugandan children with severe malaria. This resistance could hinder the effectiveness of current treatments, potentially leading to increased malaria-related deaths, particularly among vulnerable young children in Africa. A new study has revealed alarming evidence of partial resistance to artemisinin, a crucial antimalarial drug, in Ugandan children with severe malaria. This resistance could hinder the effectiveness of current treatments, potentially leading to increased malaria-related deaths, particularly among vulnerable young children in Africa. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle